Found 19550 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)
PHASE1Primary trial objective in this single arm trial is to assess the safety an...
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients
N/AA phase IV study to characterize safety of Elunate® (Fruquintinib) in Chine...
Location
Shanghai Dongfang Hospital
Effect of Acute Cardiovascular Disease on Microbiome
N/AAtherosclerotic diseases such as coronary artery disease (CAD) and peripher...
Location
University of Essen, Clinic of Cardiology and Angiology
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
PHASE1This phase I trial studies the side effects and best dose of AR-42 when giv...
Location
Cincinnati Children's Hospital
Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma
PHASE11\. Purpose of the Study - This protocol aims to demonstrate the feasibilit...
Location
Duke University Medical Center
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
PHASE3Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Location
University of Alabama at Birmingham
Living With Multimorbidity: CO-ORDINATE Program
NAMultimorbidity is common and is the coexistence of two or more chronic cond...
Location
Johns Hopkins School of Nursing
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
NAThis is a Prospective, Multicenter, Randomized Controlled study to evaluate...
Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, Hubei, P. R. China
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
PHASE3RATIONALE: Providing information that is tailored to answer patients' quest...
Location
Barbara Ann Karmanos Cancer Institute
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
PHASE2Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Location
Fudan University Shanghai Cancer Center